|
|
Volumn 343, Issue 16, 2000, Pages 1182-1183
|
|
Treatment of lupus nephritis - A work in progress
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
ANTIMETABOLITE;
AZATHIOPRINE;
COMPLEMENT;
CYCLOPHOSPHAMIDE;
FC RECEPTOR;
GLUCOCORTICOID;
HLA ANTIGEN;
IMMUNOGLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
ALLELE;
AVASCULAR NECROSIS;
CANCER;
CATARACT;
CLINICAL TRIAL;
DIABETES MELLITUS;
DISEASE ACTIVITY;
DISEASE SEVERITY;
EDITORIAL;
ENVIRONMENTAL EXPOSURE;
GENETIC PREDISPOSITION;
HERPES ZOSTER;
HUMAN;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
LUPUS ERYTHEMATOSUS NEPHRITIS;
META ANALYSIS;
OPPORTUNISTIC INFECTION;
OSTEOPOROSIS;
PATHOGENESIS;
PLASMAPHERESIS;
PRIORITY JOURNAL;
RACE;
RISK FACTOR;
SEPSIS;
STEM CELL TRANSPLANTATION;
AZATHIOPRINE;
CYCLOPHOSPHAMIDE;
DRUG THERAPY, COMBINATION;
GLUCOCORTICOIDS, SYNTHETIC;
HUMAN;
IMMUNOSUPPRESSIVE AGENTS;
LUPUS NEPHRITIS;
MYCOPHENOLIC ACID;
PREDNISOLONE;
|
|
EID: 0034687439
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200010193431610 Document Type: Editorial |
|
Times cited : (27)
|
|
References (10)
|
